Four additional grants will be awarded over the next two years.
The American Academy of Periodontology (AAP) announced that member Yvonne Kapila, DDS, Ph.D., is the first recipient of its new SUNSTAR Innovation Grant (SIG). The $30,000 research grant, a component of the AAP’s recent partnership with oral health and technology company SUNSTAR, provides support to an AAP member whose research endeavors show significant potential to advance the science and practice of periodontics.
Dr. Kapila’s research project, “Natural Bacteriocins as Pre/Pro-Biotics to Promote Oral Health and Prevent Periodontal Disease,” was selected out of 15 grant submissions. This project aims to build a foundation for using pre- or pro-biotics containing nisin (commonly used as a food preservative) or nisin-secreting bacteria to promote the maintenance of a healthy oral microbiome and to prevent the formation of pathogenic biofilms associated with periodontal disease.
“The SUNSTAR Innovation Grant will allow our team of clinicians and scientists to explore nisin’s effects on oral biofilm composition using both in vitro and in vivo model systems. Nisin has a long history of safety and broad range of biomedical applications, and it could add value in our understanding of periodontal health and periodontal disease prevention,” says Dr. Kapila, professor and vice chair of the University of California San Francisco’s Division of Periodontology. “I am so pleased and honored that this important project was chosen by the AAP and SUNSTAR to receive additional funding.”
Trending news: Scheduling Institute to send dentists to the Dominican Republic
As part of the Innovation Grant program, SUNSTAR has committed to awarding six research grants to select AAP members over a three-year period beginning in 2017. The AAP’s research submissions committee examines all abstracts against criteria established by SUNSTAR and the Academy.
“The SUNSTAR Innovation Grant not only provides generous support to innovative studies, but it also extends the reach of the Academy’s scientific agenda,” says Terrence J. Griffin, DMD, president of the AAP. “By cultivating the clinical research of our members, the grant, in turn, provides avenues for enhancing overall patient health and wellbeing.”
SUNSTAR fully supports Dr. Kapila’s selection as the grant’s inaugural winner.
“SUNSTAR and the AAP share a common interest in innovative treatments and research that serve to alleviate the high burden of periodontitis in the US,” says Aaron Pfarrer, senior director, professional relations. “We are confident that Dr. Kapila’s study will lay the groundwork for novel methods of periodontal disease prevention. We look forward to many important updates on this groundbreaking research.”
Dr. Kapila will present the results of her study at a future AAP annual meeting.
The academy encourages members who are actively conducting scientific research in a clinical setting to submit research abstracts and proposals for consideration of future grant awards. Applications will be accepted in Fall 2017. For more information on the SUNSTAR Innovation Grant, contact Scientific Affairs Manager Stephanie Heffner at stephanie@perio.org.
Dental Products Report 2023 Greater New York Dental Meeting Product Solutions Center Roundup
November 29th 2023If you can't be at the 2023 Greater New York Dental Meeting, catch up on the biggest news and most exciting products shared from the stage of the Dental Products Report Product Solution Center.
Episode 31: Dentsply Sirona Implant Announcements
September 30th 2021DPR’s Editorial Director Noah Levine sat down with Gene Dorff, Dentsply Sirona’s group vice president of implants and Dr. Dan Butterman to review several big announcements the company made in the arena of implants during Dentsply Sirona World 2021 in Las Vegas.
Study Shows Dental Opioid Prescribing Went Up During COVID-19 Pandemic
November 6th 2023A new study demonstrates that dental opioid prescribing increased during the peak of the COVID-19 pandemic, reinforcing the importance of non-opioid pain management solutions even during global health emergencies.